News & Events

• December 1, 2017
  

  A Standardised Method for Interpreting the Association Between Mutations and Phenotypic Drug Resistance in Mycobacterium Tuberculosis

• July 4, 2017
  

  Open Innovation: Towards Sharing of Data, Models and Workflows

  Conrado DJ, Karlsson MO, Romero K, Sarr C, Wilkins JJ. Open Innovation: Towards Sharing of Data, Models and Workflows. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences. 2017 Jul 4.

• May 1, 2017
  

  Tuberculosis and Antimicrobial Resistance – New Models of Research and Development Needed

  Brigden G, Castro JL, Ditiu L, Gray G, Hanna D, Low M, Matsoso MP, Perry G, Spigelman M, Swaminathan S, Torreele E, Wong S. Tuberculosis and Antimicrobial Resistance – New Models of Research and Development Needed. Bulletin of the World Health Organization. 2017 May 1;95(5):315.

• March 1, 2017
  

  Tuberculosis Eradication versus Control

  Schito M, Hanna D, Zumla A. Tuberculosis Eradication versus Control. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2017 Mar 1;56:10–3.

• March 1, 2017
  

  World TB Day 2017: Advances, Challenges and Opportunities in the “End-TB” Era

  Petersen E, Maeurer M, Marais B, Migliori GB, Mwaba P, Ntoumi F, Vilaplana C, Kim K, Schito M, Zumla A. World TB Day 2017: Advances, Challenges and Opportunities in the “End-TB” Era. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2017 Mar;56:1–5.